TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
ZNTL

Zentalis Pharmaceuticals Llc

Healthcare · Biotechnology

2.80$ -4.2% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Income Statement

Zentalis Pharmaceuticals Llc (ZNTL) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 0.0 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement ZNTL
Line item 2018 2019 2020 2021 2022 2023 2024 2025
0.0 0.0 0.0 0.0 0.0 0.0 67 0.0
– 0.1 0.2 0.5 1.4 1.4 1.3 0.7
0.0 -0.1 -0.2 -0.5 -1.4 -1.4 67 -0.7
19 38 85 176 173 235 168 107
4.9 8.5 34 41 55 59 87 38
24 47 119 217 227 300 259 153
-24 -47 -119 -217 -227 -300 -191 -153
0.0 1.2 2.2 110 2.6 – – –
-23 -46 -118 -166 -238 -293 -166 -137
0.0 0.0 0.4 -0.3 -0.5 -0.6 0.2 0.4
-21 -46 -118 -159 -237 -292 -166 -137
-24 -47 -119 -207 -234 -248 -186 -144

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?